Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon - D’Ambrosio, Roberta; Degasperi, Elisabetta; Aghemo, Alessio; Fraquelli, Mirella; Lampertico, Pietro; Rumi, Maria Grazia; Facchetti, Floriana; Grassi, Eleonora; Casazza, Giovanni; Rosenberg, William; Bedossa, Pierre; Colombo, Massimo (PloS one, 2016)
Keywords: Aged; Antiviral Agents - therapeutic use; Aspartate Aminotransferases - blood; Biology and Life Sciences; Biomarkers - blood; Biopsy; Cirrhosis; Diagnosis; Diagnostic systems; Elasticity Imaging Techniques - methods; Female; Fibrosis; Gastroenterology; Hepacivirus - drug effects; Hepacivirus - physiology; Hepatitis; Hepatitis C; Hepatitis C - drug therapy; Hepatitis C - virology; Hepatitis C virus; Hepatology; Host-Pathogen Interactions - drug effects; Humans; Interferon; Interferons - therapeutic use; Laboratories; Liver; Liver - pathology; Liver - virology; Liver cirrhosis; Liver Cirrhosis - diagnosis; Liver Cirrhosis - drug therapy; Liver Cirrhosis - virology; Male; Medical diagnosis; Medicine and Health Sciences; Middle Aged; Nuclear polyhedrosis virus; Outcome Assessment (Health Care) - methods; Patients; Platelet Count; Quality; ROC Curve; Serologic Tests; Serological tests; Surveillance; Viruses; France; Italy